Carcinoma of the nasopharynx treated by radiotherapy alone: determinants of local and regional control.
about
Biomarkers for use in monitoring responses of nasopharyngeal carcinoma cells to ionizing radiationRole of chemotherapy in nasopharyngeal carcinomaConformal radiotherapy and intensity-modulated radiotherapy--clinical data.Outpatient weekly neoadjuvant chemotherapy followed by radiotherapy for advanced nasopharyngeal carcinoma: high complete response and low toxicity rates.Comparison between nedaplatin and cisplatin plus docetaxel combined with intensity-modulated radiotherapy for locoregionally advanced nasopharyngeal carcinoma: a multicenter randomized phase II clinical trial.Sequential chemotherapy and intensity-modulated radiation therapy in the management of locoregionally advanced nasopharyngeal carcinoma: experience of 370 consecutive cases.Staging of nasopharyngeal carcinoma: from Ho's to the new UICC system.Clinicopathologic idiosyncrasies of nasopharyngeal cancer in a moderate-risk Mediterranean region.Notch1 signaling is activated in cells expressing embryonic stem cell proteins in human primary nasopharyngeal carcinoma.Preparation of human scFv antibody against nasopharyngeal carcinoma and identification of its specificity.Role of plasma EBV DNA levels in predicting recurrence of nasopharyngeal carcinoma in a Western population.Radiotherapy concurrently with weekly cisplatin, followed by adjuvant chemotherapy, for N2-3 nasopharyngeal cancer: a multicenter trial of the Forum for Nuclear Cooperation in AsiaAnalysis of late toxicity in nasopharyngeal carcinoma patients treated with intensity modulated radiation therapyEffectiveness and toxicities of intensity-modulated radiation therapy for patients with T4 nasopharyngeal carcinoma.Nasopharyngeal carcinoma: molecular biomarker discovery and progress.High serum levels of soluble CD40-L in patients with undifferentiated nasopharyngeal carcinoma: pathogenic and clinical relevance.Clinical use of intensity-modulated radiotherapy: part I.Serum antibody response to lytic and latent Epstein-Barr virus antigens in undifferentiated nasopharyngeal carcinoma patients from an area of nonendemicityLymphoepithelioma-like carcinoma of the salivary gland: is radiotherapy alone adequate?Induction chemotherapy followed by alternating chemo-radiotherapy in stage IV undifferentiated nasopharyngeal carcinoma.Nasopharygeal carcinoma in Queensland, Australia: a review of 10 years experience.MiR-593 mediates curcumin-induced radiosensitization of nasopharyngeal carcinoma cells via MDR1Prognostic factors for survival of patients with nasopharyngeal carcinoma following conventional fractionation radiotherapy.Intensity-modulated radiation therapy with or without chemotherapy for nasopharyngeal carcinoma: radiation therapy oncology group phase II trial 0225Nasopharyngeal carcinoma in Slovenia, 1990-2003 (results of treatment with conventional two-dimensional radiotherapy).The significance of diffusion tensor magnetic resonance imaging for patients with nasopharyngeal carcinoma and trigeminal nerve invasion.Metastatic retropharyngeal lymph nodes in nasopharyngeal carcinoma: imaging criteria.Endoscopic endonasal nasopharyngectomy in selected cancers.Association of inverted sinonasal papilloma with non-sinonasal head-and-neck carcinoma.Patterns of nodal failure after intensity modulated radiotherapy for nasopharyngeal carcinoma.Curcumin exerts inhibitory effects on undifferentiated nasopharyngeal carcinoma by inhibiting the expression of miR-125a-5p.AHNS Series - Do you know your guidelines? Principles of treatment for nasopharyngeal cancer: A review of the National Comprehensive Cancer Network guidelines.Neoadjuvant chemotherapy plus conventional radiotherapy or accelerated hyperfractionation in stage III and IV nasopharyngeal carcinoma--a phase II study.HPV and EBV Infections in Neck Metastases from Occult Primary Squamous Cell Carcinoma: Another Virus-Related Neoplastic Disease in the Head and Neck Region.Radiation-induced lower cranial nerve palsy in patients with head and neck carcinoma.Prognostic value of maximum standard uptake value, metabolic tumor volume, and total lesion glycolysis of positron emission tomography/computed tomography in patients with nasopharyngeal carcinoma: A systematic review and meta-analysis.Effect of AKT inhibition on epithelial-mesenchymal transition and ZEB1-potentiated radiotherapy in nasopharyngeal carcinoma.Nonnasopharyngeal lymphoepithelioma of the head and neck.Concurrent chemoradiotherapy with or without adjuvant chemotherapy in intermediate and locoregionally advanced nasopharyngeal carcinoma.The results of three different treatment modalities in patients with locally advanced nasopharyngeal carcinoma.
P2860
Q27010624-BCD83859-A7FA-4915-9692-3864F2FD40BCQ27022454-87BC9203-FDB7-467E-9F85-1CC9E176E39AQ31832138-E287CF4B-8ABE-45CB-BEB1-23232B4C40B7Q33346719-E981D731-1B59-48F2-877D-FB78D100E061Q33435906-78601426-A9DF-463D-97EB-06E4F5FE08BDQ33530564-47BE34A1-E5E3-4FA1-A078-BE45CDB4229EQ33546001-3FA64692-4496-4C0D-A9EF-6D8FB7293465Q33776991-8D15D07C-F17D-4C9F-AE99-B13648C4B31FQ33829691-89113E89-81F3-432C-8176-06DB13B17F03Q34230754-149ACBC4-6CA5-4A9A-BC64-15DFD4745D27Q34286259-25682381-15B6-4FBE-BCA5-A7878B8FE3B8Q34494991-CCF42A91-DFBB-4226-99DC-2CBEFBE0B78EQ34998661-DC9F7FB5-8652-4C45-BC22-CEA0A6D33A0EQ35114677-6D61AFA7-3DB0-4F43-977E-A4C508E0204FQ35597559-10FA65DD-9FFE-4029-95AD-3FF493CA08E8Q35674802-F5D9A28C-F499-472D-AB28-95586155F845Q35686412-679F7A0D-0A4A-469E-A6EA-158C22F3A644Q35783467-9F21691B-823B-451C-96E9-14B21ABD7C5CQ36169287-FAF00A42-F43B-4B95-86EE-A311696138E8Q36621526-24FF26B7-66E8-42F9-AAB5-AE25B61FC2DBQ36822990-E82FE602-92E2-4869-99F8-DB3362E03822Q36954160-0C679E3E-C02E-4ADC-A495-D78FD85FE852Q37075824-E4BE4E6F-04D7-43CE-8DA2-EA11E96E75FDQ37287053-536E4FD1-9ECC-48D3-A091-402FCA39DD0FQ37392152-5A2B3D55-EE98-448A-AE6B-8092EC9C0DFCQ37646707-E4128902-4E3F-4EF6-971A-103AED5DB795Q37809857-D5FE7F97-6639-4D9F-830D-4F0F3FEFFE92Q38114323-816B801B-9874-4D7C-8F1C-AA4854A089DDQ38497415-0515C867-CF02-40DE-8074-F7972B189FCDQ38903318-3CFDAA69-E96C-413C-9403-2B97BFC65382Q38988448-12F6C26F-E14A-4AAD-A453-17532EDBD3CFQ39023470-19AFC0BF-C796-4013-99F2-E8E1377A81DAQ40680191-DA5D99C6-0127-4FDB-B419-FC992E73390BQ41045517-4A98DA40-0019-4813-9E27-BD0397B19AC8Q41553766-DF42121F-7DE0-4E7F-9F45-4D734E41C402Q42360793-C2A82D15-3124-4995-AF1E-E820A7E9BE94Q42927132-AA1DA5FD-8FAD-4BCE-A197-94494579606BQ43877584-B826EC56-4932-4E0D-B742-8E0ABCB838D3Q45772336-5E526DFF-59F2-4BF7-877B-780845875884Q46849880-0E7FC96F-9554-4954-BA73-86D28A3F183E
P2860
Carcinoma of the nasopharynx treated by radiotherapy alone: determinants of local and regional control.
description
1997 nî lūn-bûn
@nan
1997 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի մարտին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Carcinoma of the nasopharynx t ...... of local and regional control.
@ast
Carcinoma of the nasopharynx t ...... of local and regional control.
@en
type
label
Carcinoma of the nasopharynx t ...... of local and regional control.
@ast
Carcinoma of the nasopharynx t ...... of local and regional control.
@en
prefLabel
Carcinoma of the nasopharynx t ...... of local and regional control.
@ast
Carcinoma of the nasopharynx t ...... of local and regional control.
@en
P2093
P1476
Carcinoma of the nasopharynx t ...... of local and regional control.
@en
P2093
Morrison WH
Sanguineti G
P304
P356
10.1016/S0360-3016(97)00104-1
P407
P577
1997-03-01T00:00:00Z